Works better with consistent, alternating day usage
Colon segments were promptly removed, carefully straightened to their natural length, and measured
[1] Retatrutide (trials): once-weekly subcutaneous administration, starting low (e.g., 2 mg) and escalating to 4, 8, or 12 mg maintenance, with slower titration used to improve tolerability
keep reconstituted solution refrigerated but never frozen
Studies have investigated DSIP's effects on gonadotropin release, growth hormone secretion, and other pituitary hormone dynamics in research models, positioning it as a compound of interest in neuroendocrine axis research